Gainers
- NKGen Biotech NKGN shares rose 33.8% to $1.48 during Monday's regular session. The company's market cap stands at $33.7 million. The company's, Q4 earnings came out 4 days ago.
- MSP Recovery LIFW shares rose 29.74% to $1.23. The company's market cap stands at $19.5 million.
- Assure Hldgs IONM stock increased by 24.31% to $0.55. The market value of their outstanding shares is at $4.9 million.
- ProKidney PROK stock increased by 22.79% to $2.5. The company's market cap stands at $154.3 million.
- iSpecimen ISPC shares increased by 19.32% to $0.34. The company's market cap stands at $3.1 million.
- GlucoTrack GCTK stock moved upwards by 18.65% to $0.97. The company's market cap stands at $26.0 million.
Losers
- Vaxxinity VAXX shares declined by 52.9% to $0.22 during Monday's regular session. The company's market cap stands at $28.4 million.
- Hepion Pharmaceuticals HEPA stock fell 28.82% to $1.43. The company's market cap stands at $7.8 million. The company's, Q4 earnings came out 4 days ago.
- Bio-Path Hldgs BPTH shares fell 28.44% to $3.07. The company's market cap stands at $2.3 million.
- Inhibikase Therapeutics IKT stock declined by 26.97% to $1.49. The market value of their outstanding shares is at $9.7 million.
- Telomir Pharmaceuticals TELO stock decreased by 24.99% to $5.99. The company's market cap stands at $177.3 million.
- Ocean Biomedical OCEA stock fell 17.05% to $1.46. The market value of their outstanding shares is at $50.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
GCTKGlucoTrack Inc
$0.3680-7.93%
HEPAHepion Pharmaceuticals Inc
$0.1657-11.9%
IKTInhibikase Therapeutics Inc
$2.83-13.2%
IONMAssure Holdings Corp
$0.100099900.0%
ISPCiSpecimen Inc
$2.1418.2%
NKGNNKGen Biotech Inc
$0.500111.6%
OCEAOcean Biomedical Inc
$0.1269-8.90%
PROKProKidney Corp
$1.50-1.32%
TELOTelomir Pharmaceuticals Inc
$4.200.48%
VAXXVaxxinity Inc
$0.005002400.0%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in